It contains a slew of complexion-perking ingredients, including three shelf-stable variations of vitamin C, tranexamic acid, ferulic acid, and niacinamideand those are just the brightening ingredients
The findings were reassuring enough that, in January 2026, the Food and Drug Administration (FDA) requested the removal of suicidal ideation and behavior warnings from the labels of GLP-1s, including Wegovy and Zepbound, after reviewing the available evidence
What foods should I avoid during semaglutide nausea periods
Current FDA labeling for semaglutide products includes warnings or precautions involving: Acute pancreatitis Acute gallbladder disease Acute kidney injury due to volume depletion Severe gastrointestinal reactions Hypoglycemia when combined with insulin or insulin secretagogues Diabetic retinopathy complications in susceptible patients Serious hypersensitivity reactions Pulmonary aspiration risk during general anesthesia or deep sedation Semaglutide labeling also contains a boxed warning regarding thyroid C-cell tumors observed in rodents
Already, Wegovy has been approved to reduce the risk of heart problems
We typically do not prescribe this medication to patients with: A personal or family history of Medullary Thyroid Carcinoma (MTC)